You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Chronic Kidney Disease in Type 2 Diabetes: Patient Selection and Education for Improved Outcomes

  1. Jessie is a 53-year-old woman with type 2 diabetes who was diagnosed with chronic kidney disease 2 years ago based on an uACR of 400. Current mediations include metformin, lisinopril, and atorvastatin. She does not have a history of urinary tract infections, her eGFR is 50, and HbA1c is 8.0%.
    According to the 2022 American Diabetes Association, which of the drug classes is recommended for patients with type 2 diabetes and chronic kidney disease?
    GLP-1 receptor agonist
    SGLT2 inhibitor
  2. If Jessie’s uACR continues to increase, an agent from which of the drug classes, as recommended by the 2022 American Diabetes Association, should be added for this patient?
    GLP-1 receptor agonist
    Nonsteroidal mineralocorticoid receptor antagonist (NS-MRA)
    Steroidal MRA